DFFVX
Price
$34.85
Change
+$0.18 (+0.52%)
Updated
Jul 3 closing price
Net Assets
13.39B
RYTFX
Price
$7.90
Change
+$0.06 (+0.77%)
Updated
Jul 3 closing price
Net Assets
958.17M
Interact to see
Advertisement

DFFVX vs RYTFX

Header iconDFFVX vs RYTFX Comparison
Open Charts DFFVX vs RYTFXBanner chart's image
DFA US Targeted Value I
Price$34.85
Change+$0.18 (+0.52%)
VolumeN/A
Net Assets13.39B
Royce Small-Cap Total Return Svc
Price$7.90
Change+$0.06 (+0.77%)
VolumeN/A
Net Assets958.17M
DFFVX vs RYTFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFFVX vs. RYTFX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and RYTFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.4B vs. RYTFX (958M). RYTFX pays higher dividends than DFFVX: RYTFX (2.50) vs DFFVX (1.63). DFFVX was incepted earlier than RYTFX: DFFVX (25 years) vs RYTFX (24 years). RYTFX (1.54) is less costly to investors than DFFVX (0.30). RYTFX is a more actively managed with annual turnover of: 51.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than RYTFX: DFFVX (0) vs RYTFX (2000). DFFVX annual gain was more profitable for investors over the last year : 11.79 vs. RYTFX (4.99). DFFVX return over 5 years is better than : 116.56 vs. RYTFX (-6.25).
DFFVXRYTFXDFFVX / RYTFX
Total Expense Ratio0.291.4919%
Annual Report Gross Expense Ratio0.301.5419%
Fund Existence25 years24 years-
Gain YTD2.3310.1391,674%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.4B958M1,399%
Annual Yield % from dividends1.632.5065%
Returns for 1 year11.794.99236%
Returns for 3 years37.516.79552%
Returns for 5 years116.56-6.25-1,864%
Returns for 10 years62.84-40.46-155%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXS5.810.08
+1.40%
Astria Therapeutics
RTLLF828.00N/A
N/A
Rational AG
MGLD0.78N/A
N/A
Marygold Companies (The)
DDHRF2.06N/A
N/A
Dream Impact Trust
SOIEF24.75N/A
N/A
Stolt-Nielsen Ltd